Anthera Pharmaceuticals (ANTH)
OTHER OTC:ANTH
US Market
Holding ANTH?
Track your performance easily

Anthera Pharmaceuticals (ANTH) Income Statement

233 Followers

Anthera Pharmaceuticals Income Statement

Last quarter (Q ), Anthera Pharmaceuticals's total revenue was $―, a decrease of ― from the same quarter last year. In Q, Anthera Pharmaceuticals's net income was $-6.02M. See Anthera Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 17Dec 16Dec 15Dec 14Dec 13
Total Revenue
--$ 145.00K$ 3.19M--
Cost of Revenue
------
Gross Profit
--$ 145.00K$ 3.19M--
Operating Expense
$ -14.86M$ 36.43M$ 57.32M$ 38.43M$ 28.46M$ 28.25M
Operating Income
$ -36.80M$ -36.43M$ -57.18M$ -35.24M$ -28.46M$ -28.25M
Net Non Operating Interest Income Expense
$ 6.54M-$ 1.65M$ 51.00K$ -1.05M$ -2.61M
Other Income Expense
$ -10.12M$ -9.56M$ -1.65M$ -23.00K$ 96.00K$ -17.00K
Pretax Income
$ -20.14M$ -26.87M$ -55.52M$ -35.22M$ -29.60M$ -30.84M
Tax Provision
$ -28.63M$ -28.93M$ -8.94M$ -1.00K$ -1.40M$ -1.40M
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -21.68M$ -29.38M$ -66.44M$ -35.22M$ -29.60M$ -30.84M
Basic EPS
$ -0.97-----
Diluted EPS
$ -1.25$ -2.86$ -12.88$ -7.92$ -10.88$ -13.52
Basic Average Shares
$ 53.53M$ 10.28M$ 5.16M$ 4.45M$ 2.72M$ 2.28M
Diluted Average Shares
$ 43.25M$ 10.28M$ 5.16M$ 4.45M$ 2.72M$ 2.28M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ -14.86M$ 36.43M$ 57.32M$ 38.43M$ 28.46M$ 28.25M
Net Income From Continuing And Discontinued Operation
$ -25.00M$ -26.87M$ -55.52M$ -35.22M$ -29.60M$ -30.84M
Normalized Income
------
Interest Expense
------
EBIT
$ -18.54M$ -26.87M$ -55.52M$ -35.22M$ -28.55M$ -28.25M
EBITDA
$ -13.95M$ -26.59M$ -55.26M$ -34.94M$ -27.77M$ -26.72M
Currency in USD

Anthera Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis